Kai‐Wei Yu

452 total citations
31 papers, 290 citations indexed

About

Kai‐Wei Yu is a scholar working on Molecular Biology, Cell Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kai‐Wei Yu has authored 31 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cell Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kai‐Wei Yu's work include Microtubule and mitosis dynamics (7 papers), Cerebrovascular and Carotid Artery Diseases (5 papers) and Neurological diseases and metabolism (4 papers). Kai‐Wei Yu is often cited by papers focused on Microtubule and mitosis dynamics (7 papers), Cerebrovascular and Carotid Artery Diseases (5 papers) and Neurological diseases and metabolism (4 papers). Kai‐Wei Yu collaborates with scholars based in China, Taiwan and United States. Kai‐Wei Yu's co-authors include Zhen‐Yu She, Liang Yang, Peng Xue, Yang Fu, Lin Yang, Nuo Yang, Xueyan Liu, Dimitri Papukashvili, Jiao Zhao and Xingyun Wang and has published in prestigious journals such as Applied and Environmental Microbiology, International Journal of Molecular Sciences and International Journal of Environmental Research and Public Health.

In The Last Decade

Kai‐Wei Yu

30 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai‐Wei Yu China 10 131 62 40 36 36 31 290
Guilhem Clary France 10 139 1.1× 25 0.4× 23 0.6× 9 0.3× 42 1.2× 12 342
M. Albrechtsen Denmark 12 190 1.5× 34 0.5× 34 0.8× 21 0.6× 14 0.4× 22 429
Wangfei Wang United States 5 140 1.1× 20 0.3× 15 0.4× 6 0.2× 20 0.6× 10 282
Siji Nian China 11 104 0.8× 19 0.3× 15 0.4× 42 1.2× 7 0.2× 29 287
Emma Tabe Eko Niba Japan 12 342 2.6× 10 0.2× 37 0.9× 23 0.6× 90 2.5× 34 479
Katharina Roß Germany 6 335 2.6× 20 0.3× 24 0.6× 14 0.4× 43 1.2× 11 436
Michel Ragno France 11 263 2.0× 11 0.2× 56 1.4× 48 1.3× 60 1.7× 13 349
Aurélie Guého Switzerland 9 130 1.0× 146 2.4× 40 1.0× 4 0.1× 16 0.4× 13 291
Barrett L. Updegraff United States 6 169 1.3× 20 0.3× 173 4.3× 30 0.8× 52 1.4× 10 375

Countries citing papers authored by Kai‐Wei Yu

Since Specialization
Citations

This map shows the geographic impact of Kai‐Wei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai‐Wei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai‐Wei Yu more than expected).

Fields of papers citing papers by Kai‐Wei Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai‐Wei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai‐Wei Yu. The network helps show where Kai‐Wei Yu may publish in the future.

Co-authorship network of co-authors of Kai‐Wei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Kai‐Wei Yu. A scholar is included among the top collaborators of Kai‐Wei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai‐Wei Yu. Kai‐Wei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Ruizhe, Boyi Liu, Wenchao Zhang, et al.. (2025). Identifying the causal relationship between gut microbiota and lymphoma disease: a Mendelian randomization study and meta-analysis. Archives of Medical Science. 1 indexed citations
3.
Wu, Chia‐Hung, Shih‐Pin Chen, Chih‐Ping Chung, et al.. (2024). Early Improvement in Interstitial Fluid Flow in Patients With Severe Carotid Stenosis After Angioplasty and Stenting. Journal of Stroke. 26(3). 415–424. 3 indexed citations
4.
Yu, Kai‐Wei, et al.. (2023). Biallelic DDHD2 mutations in patients with adult‐onset complex hereditary spastic paraplegia. Annals of Clinical and Translational Neurology. 10(9). 1603–1612. 4 indexed citations
5.
Yu, Kai‐Wei, et al.. (2023). Clinical and genetic characterization of NIPA1 mutations in a Taiwanese cohort with hereditary spastic paraplegia. Annals of Clinical and Translational Neurology. 10(3). 353–362. 2 indexed citations
7.
Wu, Chia‐Hung, Shu‐Ting Chen, Kai‐Wei Yu, et al.. (2023). Clinical and imaging findings for the evaluation of large Rathke’s cleft cysts and cystic craniopharyngiomas. Pituitary. 26(4). 393–401. 6 indexed citations
8.
Li, Biao, et al.. (2023). The Mature COC Promotes the Ampullary NPPC Required for Sperm Release from Porcine Oviduct Cells. International Journal of Molecular Sciences. 24(4). 3118–3118. 2 indexed citations
9.
Wu, Chia‐Hung, Chih‐Ping Chung, Kai‐Wei Yu, et al.. (2023). Prevention of in-stent restenosis with drug-eluting balloons in patients with postirradiated carotid stenosis accepting percutaneous angioplasty and stenting. Journal of NeuroInterventional Surgery. 16(1). 73–80. 5 indexed citations
10.
Liao, Yi‐Chu, Kon‐Ping Lin, Po‐Yu Lin, et al.. (2022). Investigating KIF1A mutations in a Taiwanese cohort with hereditary spastic paraplegia. Parkinsonism & Related Disorders. 103. 144–149. 3 indexed citations
11.
Qu, Jiuxin, Zhao Cai, Xiangke Duan, et al.. (2022). Pseudomonas aeruginosa modulates alginate biosynthesis and type VI secretion system in two critically ill COVID-19 patients. Cell & Bioscience. 12(1). 14–14. 11 indexed citations
12.
Hsueh, Hsueh‐Wen, Shih‐Ying Chen, Yung‐Yee Chang, et al.. (2021). Clinical and genetic characterization of hereditary spastic paraplegia type 3A in Taiwan. Parkinsonism & Related Disorders. 87. 87–91. 8 indexed citations
13.
Liu, Yi‐Hong, Yuh‐Cherng Guo, Ching‐Piao Tsai, et al.. (2021). Treatment response, risk of relapse and clinical characteristics of Taiwanese patients with neuromyelitis optica spectrum disorder. Journal of the Formosan Medical Association. 121(9). 1647–1656. 9 indexed citations
14.
Wang, Jing, Xi Liu, Kai‐Wei Yu, et al.. (2021). Psl-Dependent Cooperation Contributes to Drug Resistance of Pseudomonas aeruginosa in Dual-Species Biofilms with Acinetobacter baumannii. ACS Infectious Diseases. 8(1). 129–136. 6 indexed citations
15.
She, Zhen‐Yu, et al.. (2020). Kinesin-5 Eg5 is essential for spindle assembly and chromosome alignment of mouse spermatocytes. Cell Division. 15(1). 6–6. 15 indexed citations
16.
She, Zhen‐Yu, et al.. (2020). Kinesin-7 CENP-E regulates the formation and structural maintenance of the acrosome. Cell and Tissue Research. 383(3). 1167–1182. 6 indexed citations
17.
Yu, Kai‐Wei, et al.. (2020). Kinesin-7 CENP-E regulates cell division, gastrulation and organogenesis in development. European Journal of Cell Biology. 99(6). 151107–151107. 6 indexed citations
18.
She, Zhen‐Yu, et al.. (2020). Kinesin-7 CENP-E regulates chromosome alignment and genome stability of spermatogenic cells. Cell Death Discovery. 6(1). 25–25. 13 indexed citations
19.
Yu, Kai‐Wei, et al.. (2019). Mechanisms of kinesin‐7 CENP‐E in kinetochore–microtubule capture and chromosome alignment during cell division. Biology of the Cell. 111(6). 143–160. 18 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026